Nathaniel Robichaud

Nathaniel leads scientific partnerships at Nomic Bio, where he works with leading scientists to design, implement, and analyze high-throughput proteomics experiments based on the Nomic platform. He also collaborates with drug discovery teams to develop new proteomics capabilities tailored to their research needs. His current focus involves generating large-scale proteomics-based datasets to characterize therapeutic effects and capture potential toxicities. His work in collaboration with academic institutions has enabled population scale biomarker discovery studies in immuno-oncology settings, and empowered the inclusion of protein profiling in multi-omics studies, enhancing the mechanistic understanding of drug treatments and biological processes. Prior to his work at Nomic, Nathaniel completed doctoral and postdoctoral studies at McGill University and NYU, studying the interactions between cancer and immune cells and how they are regulated at the level of protein synthesis.